Cahill Financial Advisors’s Sanofi SNY Stock Holding History

Cahill Financial Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-109	Closed	-$5K	–	686
2021 Q3	$5K	Buy	+109	New	+$5.54K	﹤0.01%	690

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Cahill Financial Advisors's SNY Position: Q4 2021 in Review

Cahill Financial Advisors sold out of Sanofi (SNY) in Q4 2021, closing a stake of 109 shares — an estimated $5K sold.

Cahill Financial Advisors first reported a position in SNY in Q3 2021 and held it in 1 quarter. The position peaked at $5K in Q3 2021. 624 funds tracked by Wall St. Rank hold SNY as of Q4 2021.

Cahill Financial Advisors reported no remaining Sanofi position as of Q4 2021 after selling out during the quarter.
Cahill Financial Advisors sold 109 Sanofi shares in Q4 2021, an estimated $5K.
Cahill Financial Advisors first reported a position in Sanofi in Q3 2021 and held it in 1 quarter.
Cahill Financial Advisors's Sanofi position peaked at $5K in Q3 2021.
624 funds tracked by Wall St. Rank held Sanofi as of Q4 2021.

Based on Cahill Financial Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.